Skip to main content

September 2023 Vol 16, Payers' Guide to FDA Updates

Introduction
Welcome to the 2023 PAYERS’ GUIDE TO FDA UPDATES: Latest Approvals, Upcoming Decisions
Read More
A Payer Perspective
Challenges Facing the US Healthcare System in 2023 and Beyond: A Payer Perspective
Gary M. Owens, MD
Read More
FDA Approvals
IMJUDO (Tremelimumab-actl) in Combination With IMFINZI (Durvalumab) Receives FDA Approval for HCC and NSCLC
Jerm Day-Storms, PhD, MWC
Read More
FDA Approvals
FDA Approval of SYFOVRE (Pegcetacoplan) and IZERVAY (Avacincaptad Pegol) Reshapes Management of GA
Jerm Day-Storms, PhD, MWC
Read More
FDA Approvals
FDA Pipeline, October-December 2023
Read More
FDA Approvals
FDA Approvals of Brand-Name Prescription Drugs, October 4, 2022, Through August 4, 2023
Read More

Results 1 - 6 of 6